Longevity Research10 min read·Published August 10, 2026

Mitochondrial DNA and Disease: What Patients Should Know

How mtDNA mutations can affect energy production, symptoms, testing, inheritance, and treatment limits.

Mitochondrial DNA and Disease: What Patients Should Know

Mitochondrial DNA is a small set of genetic instructions inside mitochondria, the cell structures that help make energy. Mutations in mitochondrial DNA can cause rare, often multisystem diseases such as MELAS, MERRF, Leigh syndrome, LHON, Kearns-Sayre syndrome, and mitochondrial DNA depletion syndromes. Diagnosis usually needs specialist genetic and biochemical testing 2, 4, 6.

Not sure where to start? Take the 3-min clinical quiz.

See if you qualify →

What is mitochondrial DNA, and why does it matter?

Mitochondrial DNA is DNA found inside mitochondria, not in the cell nucleus. Humans have 37 mitochondrial genes, while most genes sit in nuclear DNA; that split matters because either genome can cause mitochondrial disease when the wrong gene is changed 5.

How mitochondrial DNA differs from nuclear DNA

Nuclear DNA is packaged in chromosomes in the nucleus and is inherited from both biological parents. Mitochondrial DNA, often shortened to mtDNA, is found inside mitochondria and is passed mainly from mother to child, so its inheritance pattern is different 1.

Why mitochondria are important for energy production

Mitochondria help turn food and oxygen into ATP through oxidative phosphorylation. ATP is the energy molecule cells use for many basic tasks, so problems in this system can affect tissues that need constant energy 3.

Why high-energy organs are often affected

The brain, muscles, heart, eyes, liver, nerves, and digestive tract use a lot of energy. That is why mitochondrial disease often looks multisystem rather than like one single organ problem 2.

How can mitochondrial DNA mutations cause disease?

mtDNA mutations can disrupt the proteins and RNA molecules mitochondria need for oxidative phosphorylation. The same mutation can cause different symptoms because cells may carry a mix of normal and abnormal mtDNA, sometimes for many years before symptoms are clear 4.

Energy production and oxidative phosphorylation

Oxidative phosphorylation is the final pathway mitochondria use to make much of the cell’s ATP. If a mutation blocks this pathway, cells may have trouble meeting energy needs, especially during illness, fasting, growth, or physical stress 3.

Heteroplasmy and threshold effects

Heteroplasmy means a person has both normal and mutated mtDNA in the same cell or tissue. A threshold effect means symptoms may appear only when the mutation load is high enough in a specific tissue, which helps explain why one person may have eye symptoms while another has muscle or brain symptoms 4.

Maternal inheritance and de novo changes

Many mtDNA conditions are maternally inherited, because mtDNA is passed through the egg. Some mitochondrial disease also comes from new, or de novo, changes, and many cases come from nuclear DNA mutations inherited in standard Mendelian patterns 1, 2.

What diseases are associated with mitochondrial DNA?

Mitochondrial diseases are a broad group, not one diagnosis. Reviews list disorders such as MELAS, MERRF, Leigh syndrome, LHON, Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia, Pearson syndrome, mitochondrial DNA depletion syndromes, and mitochondrial myopathy among recognized mitochondrial disease presentations 6.

ConditionCommonly involved systemsPlain-language note
MELASBrain, muscles, metabolismMELAS stands for mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes; it can involve seizures, headaches, weakness, and stroke-like events 6.
MERRFBrain, muscles, nervesMERRF stands for myoclonic epilepsy with ragged-red fibers; it can involve muscle jerks, seizures, and myopathy 6.
Leigh syndromeBrain, movement, breathing, developmentLeigh syndrome is a severe mitochondrial disorder often linked with neurologic decline, though causes can be mtDNA or nuclear DNA 2.
LHONOptic nerveLeber hereditary optic neuropathy can cause painless central vision loss, often in young adults 7.
Kearns-Sayre syndrome and CPEOEyes, muscles, heart conductionThese conditions can cause drooping eyelids, limited eye movement, and other systemic findings 6.
Mitochondrial DNA depletion syndromesMuscle, liver, brain, or multiple organsThese syndromes involve too little mtDNA in affected tissue and can include TK2 deficiency and other nuclear gene causes 8.
Pearson marrow-pancreas syndromeBlood, pancreas, growthPearson syndrome is linked to large mtDNA deletions and can cause marrow failure and pancreatic problems 6.
MNGIEDigestive tract, nerves, musclesMNGIE stands for mitochondrial neurogastrointestinal encephalomyopathy and often involves severe digestive and neurologic symptoms 6.

How rare is mitochondrial disease?

Mitochondrial disease is rare, but exact numbers are hard to pin down. One adult population study in northern England estimated that pathogenic mtDNA mutations affected about 1 in 5,000 adults, while many more people carried mtDNA variants that might or might not cause disease 9.

Rare diseases can still be underdiagnosed. Symptoms overlap with common conditions, genetic testing has changed over time, and a person may see several specialists before mitochondrial disease is considered 2.

What symptoms can mitochondrial DNA disease cause?

Mitochondrial DNA disease can affect almost any high-energy tissue. Symptoms can vary even within the same family because heteroplasmy and threshold effects can differ by tissue and over a lifetime 4.

  • Neurologic symptoms can include seizures, stroke-like episodes, neuropathy, migraine-like headaches, ataxia, developmental delay, or cognitive changes 2.
  • Muscle symptoms can include weakness, exercise intolerance, cramps, myopathy, or episodes of worsening after illness or stress 6.
  • Eye and hearing symptoms can include optic neuropathy, drooping eyelids, limited eye movement, or hearing loss 7.
  • Heart, liver, blood, and digestive involvement can occur in some mitochondrial syndromes, including cardiomyopathy, liver disease, marrow problems, diabetes, constipation, or swallowing trouble 2, 6.

What is the difference between mitochondrial disease and mitochondrial dysfunction?

Primary mitochondrial disease means there is a disease-causing mutation in mtDNA or nuclear DNA that directly impairs mitochondrial function. Secondary mitochondrial dysfunction means mitochondria are affected as part of another illness, exposure, aging process, or metabolic stress; the distinction changes testing and treatment decisions 2.

This matters because a supplement, peptide, diet, or biomarker result cannot prove that a person has a genetic mitochondrial disease. It also cannot prove that a therapy changes human lifespan; longevity research must separate human clinical outcomes from observational, animal, and cell evidence 2, 10.

How do doctors test for mitochondrial DNA disease or dysfunction?

Testing for mitochondrial disease usually starts with the story: symptoms, exam, family history, and which organs are involved. There is no single one-test answer, so clinicians often combine genetic testing, metabolic labs, imaging, and sometimes tissue testing 4.

  1. 1Clinical history and family history: clinicians look for multisystem patterns, maternal inheritance, childhood or adult onset, neurologic symptoms, exercise intolerance, vision loss, hearing loss, or unexplained organ disease 4.
  2. 2Genetic testing: modern testing may include mtDNA sequencing, deletion testing, and nuclear gene panels or exome/genome sequencing, because nuclear DNA can also cause mitochondrial disease 2.
  3. 3Blood, urine, and metabolic markers: lactate, pyruvate, amino acids, organic acids, acylcarnitines, creatine kinase, and other markers may support the picture but are not perfect rule-in or rule-out tests 4.
  4. 4Muscle or tissue biopsy: in selected cases, tissue testing may look for ragged-red fibers, respiratory chain enzyme activity, mtDNA depletion, or mutation load in the affected tissue 4.
  5. 5Specialist referral: a genetics, metabolic, neurology, ophthalmology, cardiology, or mitochondrial disease specialist may be needed when symptoms are complex or testing is unclear 2.

Can mitochondrial DNA diseases be treated?

Mitochondrial DNA diseases can often be managed, but most do not have a cure. A regulatory review reported no FDA-approved therapies in the United States for mitochondrial diseases at the time of publication, while idebenone was approved in Europe for LHON and taurine in Japan for prevention of stroke-like events in MELAS 2.

Care is usually supportive and condition-specific. That may mean treating seizures, heart rhythm problems, diabetes, hearing loss, vision loss, feeding problems, liver disease, sleep problems, or exercise intolerance with the right specialist team 2.

Many treatments historically used in mitochondrial disorders have been supplements or off-label drugs rather than approved disease-modifying therapies, and they should be reviewed with a qualified specialist. Reviews emphasize that translating molecular knowledge into proven therapies is hard because rare mitochondrial diseases often create small, genetically defined groups for trials 6.

What about gene therapy and mitochondrial replacement?

Gene therapy is being studied for selected mitochondrial diseases, especially some nuclear-gene and eye-related conditions. But experimental research is not the same as proven clinical treatment, and rare disease drug development still requires rigorous evidence, natural history studies, outcome measures, biomarkers, and sometimes surrogate endpoints 2.

Mitochondrial replacement technology, or MRT, uses donor mitochondria in reproductive cells as a possible way to reduce transmission of certain mtDNA disorders. The FDA says MRT introduces genetic modification, raises safety concerns, and that since December 2015, U.S. appropriations restrictions have prevented FDA from accepting applications for clinical research using MRT in humans 1.

What foods or lifestyle habits support mitochondria?

Mitochondria respond to basic health inputs such as nutrition, sleep, activity, and avoiding harmful exposures. But a diet, supplement, peptide, or longevity protocol cannot correct a pathogenic mtDNA mutation, and no lifestyle plan has been proven to extend human lifespan by fixing mitochondrial DNA disease 2, 10.

For people with suspected or known mitochondrial disease, diet changes should be clinician-guided. Some people need careful planning around fasting, illness, diabetes, swallowing problems, liver disease, or metabolic stress, so a genetics clinician or metabolic dietitian may be important 4.

How does Chia approach mitochondrial DNA disease topics?

Chia writes about mitochondrial biology because it is central to longevity research, energy metabolism, and healthy aging science. But mitochondrial DNA disease is a specialist medical area, and Chia does not diagnose or treat mitochondrial DNA disease.

Our role here is education: helping patients understand the difference between primary mitochondrial disease, secondary mitochondrial dysfunction, and early-stage longevity claims. If you have multisystem symptoms, neurologic symptoms, unexplained exercise intolerance, vision loss, hearing loss, or a family history, the right next step is evaluation by a qualified clinician, often a genetics, neurology, metabolic, or mitochondrial disease specialist 2, 4.

At Chia, we are careful not to overstate biomarker, animal, or cell findings. Those studies can be useful for understanding mechanisms, but they are not proof that a treatment reverses mtDNA mutations, cures mitochondrial disease, or extends human lifespan.

FAQ

References

  1. 1.U.S. Food and Drug Administration. Advisory on Legal Restrictions on the Use of Mitochondrial Replacement Techniques to Introduce Donor Mitochondria. FDA, 2024.
  2. 2.Zeviani M, Viscomi C. Regulatory environment for novel therapeutic development in mitochondrial diseases. Molecular Genetics and Metabolism, 2022.
  3. 3.Mitchell P. Coupling of phosphorylation to electron and hydrogen transfer by a chemi-osmotic type of mechanism. Nature, 1961.
  4. 4.Parikh S, Goldstein A, Koenig MK, et al. Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society. Genetics in Medicine, 2015.
  5. 5.Anderson S, Bankier AT, Barrell BG, et al. Sequence and organization of the human mitochondrial genome. Nature, 1981.
  6. 6.Kerr DS. Drug development for rare mitochondrial disorders. Neurotherapeutics, 2013.
  7. 7.Yu-Wai-Man P, Griffiths PG, Chinnery PF. Mitochondrial optic neuropathies: disease mechanisms and therapeutic strategies. Progress in Retinal and Eye Research, 2011.
  8. 8.Saada A. Mitochondrial DNA depletion syndrome: advances in molecular basis and future prospects. Molecular Genetics and Metabolism, 2004.
  9. 9.Gorman GS, Schaefer AM, Ng Y, et al. Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease. Annals of Neurology, 2015.
  10. 10.National Institutes of Health, National Heart, Lung, and Blood Institute. Mitochondrial DNA Mutations in Heart, Lung and Blood Diseases. NIH Guide, 1996.

About this article

Chia Health Editorial TeamEvidence-reviewed health education

This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.

AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.

Get a personalized plan

Find what fits your body and your goals.

Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.

Take the 3-min quiz

Keep reading

Back to all guides